This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
$1 buys you full access to ALL of TheStreet's Subscription Services! Learn More

Prana Biotech: Small-Cap Winner

Stocks in this article: PRANAENREESHZAVLDANGCRYP

NEW YORK ( TheStreet) -- Prana Biotechnology (PRAN) was skyrocketing for the second straight day Tuesday after it published data in the science journal PLoS One on the ability of its drug PBT2 to restore cognition in mice stricken by Alzheimer's disease. The stock was soaring 43% to $3.90. Volumes jumped to nearly 22 million in noon trading. Volumes have typically been under 300,000 in the last three months.

Adeona Pharmaceuticals (AEN) was another pharmaceutical company gaining on unusual volumes, climbing 18.8% to $1.75. There were no company announcements driving the move, although Adeona is developing a clinical-stage oral, gastro-retentive and sustained-release medical food candidate for the dietary management of Alzheimer's.

Rare earth stocks were gaining after China rare earth exports data showed prices were more than double last year's average. China's exports of rare earth metals burst through the $100,000-per-ton mark for the first time in February, up almost nine-fold from a year before, while the volume of trade stayed far below historical averages, according to a Reuters report. The stock of Rare Element Resources (REE) was jumping 13% to $11.72.

Shares of China GengSheng Minerals (CHGS) and China Shen Zhou (SHZ) gained 32% and 19% respectively. Avalon Rare Metals (AVL) and Qiao Xing Universal Resources (XING) also gained.

Chinese internet stock Dangdang (DANG) was gaining 8.7% to $20.56 after Piper Jaffray upgraded the stock to overweight from neutral but lowered its price target to $25 from $30 previously.

Shares of online gaming software company Cryptologic (CRYP) were surging 17% to $1.28 after its fourth-quarter loss narrowed to 6 cents a share from $1.98.

--Written by Shanthi Bharatwaj in New York



>To contact the writer of this article, click here: Shanthi Bharatwaj.

>To follow the writer on Twitter, go to http://twitter.com/shavenk.

>To submit a news tip, send an email to: tips@thestreet.com.

Disclosure: TheStreet's editorial policy prohibits staff editors and reporters from holding positions in any individual stocks.

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!

Markets

DOW 17,877.37 +49.62 0.28%
S&P 500 2,072.30 -0.53 -0.03%
NASDAQ 4,807.0470 +19.73 0.41%

Brokerage Partners

Rates from Bankrate.com

  • Mortgage
  • Credit Cards
  • Auto

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs